CClinicalTrials.gg
CompletedNCT02925598AILMALCUpdated May 9, 2017

AuraGainTM and I-Gel® Laryngeal Masks in General Anesthesia for Laparoscopic Cholecystectomy

An interventional study of I-gel LMA insertion and AuraGain LMA insertion in Respiratory Aspiration of Gastric Content, sponsored by Adiyaman University Research Hospital. Completed. Open to participants aged 18 Years to 80 Years. Per ClinicalTrials.gov, last updated 2017-05-09.

Sponsored by Adiyaman University Research Hospital · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
114
Allocation
Randomized
Ages
18 Years to 80 Years
Sex
All
01

Study summary

The standard procedure used for airway control in general anesthesia for LC (laparoscopic cholecystectomy) is endotracheal intubation (EI). AuraGain and I-Gel are supraglottic airway devices (SADs) used for airway control for certain types of surgeries. The aim of this study was to evaluate and compare the performances of new types of SADs with EI regarding their insertion times, durations, perioperative complications and effects on hemodynamic parameters and peak airway pressures (Paw) in LC as well.

Read the detailed description

The standard procedure used for airway control in general anesthesia for LC (laparoscopic cholecystectomy) is endotracheal intubation (EI). AuraGain and I-Gel are supraglottic airway devices (SADs) used for airway control for certain types of surgeries.Previous studies have investigated and/or compared the performance of ProSeal™ LMA (Intavent Orthofix, Maidenhead, UK) during LC. But the performances of I-Gel and AuraGain have not been studied well yet. The main aim of this study was to evaluate and compare the performances of new types of SADs (i.e. AuraGain and I-Gel) with endotracheal intubation regarding their insertion times, ease of insertion and perioperative complications. The secondary aim was to observe their effects on hemodynamic parameters and peak airway pressures.

02

Conditions studied

  • Respiratory Aspiration of Gastric Content

Keywords

  • Laringeal masks
  • Cholecystectomy, Laparascopic
  • Intubation, intratracheal
03

In context

Respiratory Aspiration of Gastric Contents

28 studies on the registry are indexed under Respiratory Aspiration of Gastric Contents; 6 are open to participants now.

This study's enrollment of 114 is close to the median of 113 across 16 interventional studies indexed under Respiratory Aspiration of Gastric Contents.

Browse Respiratory Aspiration of Gastric Contents studies →

Lead sponsor

Adiyaman University Research Hospital is the lead sponsor of 48 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • (ASA) 1-2 physical status scheduled for elective LC

Exclusion criteria

Exclusion Criteria:

  • under the age of 18, history of hiatus hernia, gastroesophageal reflux, body mass index (BMI) > 30 kg m-2, ASA physical status 3 or over and patients who met the difficult intubation criteria
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Crossover assignment
Masking
Single (Care provider)
Enrollment
114 participants (actual)

Study arms

  • Experimental
    I-gel LMA

    I-gel LMA insertion: I-gel insertion was done in supine position and with a standard gel pillow with the patient's head on following anesthesia induction. The insertion was verified with the manual ventilation of the patient and EtCO2 waveform.

    Device: I-gel LMA insertion

  • Experimental
    AuraGain LMA

    AuraGain insertion:AuraGain LMA insertion was done in supine position and with a standard gel pillow with the patient's head on following anesthesia induction. The insertion was verified with the manual ventilation of the patient and EtCO2 waveform.

    Device: AuraGain LMA insertion

  • Experimental
    Endotracheal tube (ETT)

    Endotracheal tube insertion: Endotracheal tube (ETT) insertion was done in supine position and with a standard gel pillow with the patient's head on following anesthesia induction. The insertion was verified with the manual ventilation of the patient and EtCO2 waveform.

    Device: ETT insertion

Interventions

  • DeviceI-gel LMA insertion

    'I-gel LMA insertion' was done following anesthesia induction.

  • DeviceAuraGain LMA insertion

    'AuraGain LMA insertion' was done following anesthesia induction.

  • DeviceETT insertion

    'ETT insertion' was done following anesthesia induction.

06

What researchers measure

Primary outcomes

  1. Insertion time

    It was assessed that how many secs it takes to insert the device

    Time frame: Perioperative

  2. Attempts to insertion

    It was assessed that how many attempts needed to insert the device

    Time frame: Perioperative

  3. Airway related complications

    Airway related complications like bronchospasm,gastric regurgitation,smooth tissue damages were assessed

    Time frame: Perioperative

Secondary outcomes

  1. Heart Rate bpm

    Heart rates changes were evaluated preoperative and after device insertion and then in every 5 mins.

    Time frame: Perioperative

  2. Systolic blood pressure mmHg

    Systolic blood pressure changes were evaluate preoperative,following device insertion then in every 5 mins.

    Time frame: Perioperative

  3. Diastolic blood pressure mmHg

    Diastolic blood pressures were evaluated preoperative,following device insertion then in every 5 mins.

    Time frame: Perioperative

  4. Peak airway pressure

    During the surgery peak airway pressures were assessed following device insertion snd then in every 5 mins.

    Time frame: Perioperative

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 9, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02925598
Lead sponsor
Adiyaman University Research Hospital
Responsible party
Dr. Ülkü Sabuncu (Principal Investigator, Ulku Sabuncu, MD, Anesthesiology and Reanimation, Adiyaman University Research Hospital) — Principal investigator
First posted
Oct 6, 2016
Start date
Jan 2015
Primary completion
Apr 2015
Completion
Apr 2015
Last update
May 9, 2017

Study contacts

Ulku Sabuncu, MD
principal investigator · Adiyaman university Research and Educational Hospital

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion